糖尿病并发症与持续葡萄糖监测衍生的血糖管理指标
本综述检索PubMed和Embase 2010年1月1日至2020年8月22日文献,最终纳入34篇、共20852例参与者(1型糖尿病663例,2型糖尿病19909例)。血糖变异性及较低的目标范围内时间(TIR)与所有研究的糖尿病微血管和大血管并发症相关,TIR关联最一致;周围神经病变主要与血糖标准差(SD)和平均血糖波动幅度(MAGE)相关。
要点
- 血糖变异性及低TIR与所有研究的糖尿病微血管和大血管并发症相关。
- 较高TIR与白蛋白尿、视网膜病变、心血管病死亡、全因死亡及颈动脉内膜中层厚度异常风险降低相关。
- 周围神经病变主要与血糖SD和MAGE相关;TIR是关联最一致的指标。
核心结论
- 证据支持糖尿病并发症与CGM衍生的日内血糖变异性指标之间存在关联,TIR是最一致的指标,支持其在临床实践中日益重要的作用。
- 需要更多纵向研究和试验来确认这些关联,尤其是1型糖尿病,其数据有限。
研究设计与样本
- 本综述检索PubMed和Embase数据库2010年1月1日至2020年8月22日的文献,使用1型糖尿病、2型糖尿病、糖尿病相关微血管和大血管并发症及血糖变异性指标等检索词。
- 排除未使用CGM的研究,以及涉及非糖尿病、急性病(卒中后、术后)、妊娠或使用胰岛素泵参与者的研究。
- 共识别1636条记录,排除1602条,最终纳入34篇文献。
- 共20852例参与者,其中663例为1型糖尿病(T1D),19909例为2型糖尿病(T2D)。
主要发现
- 血糖变异性及较低的目标范围内时间(TIR)与所有研究的糖尿病微血管和大血管并发症均显示关联。
- 较高的TIR与白蛋白尿、视网膜病变、心血管病死亡、全因死亡及颈动脉内膜中层厚度异常风险降低相关。
- 周围神经病变主要与血糖水平标准差(SD)和平均血糖波动幅度(MAGE)相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要更多纵向研究和试验来确认这些关联,尤其是1型糖尿病,其数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Although glycated hemoglobin A1c is currently the best parameter used clinically to assess risk for the development of diabetes complications, it does not provide insight into short-term fluctuations in glucose levels. This review summarizes the relationship between continuous glucose monitoring (CGM)-derived metrics of glycemic variability and diabetes-related complications. EVIDENCE ACQUISITION: PubMed and Embase databases were searched from January 1, 2010 to August 22, 2020, using the terms type 1 diabetes, type 2 diabetes, diabetes-related microvascular and macrovascular complications, and measures of glycaemic variability. Exclusion criteria were studies that did not use CGM and studies involving participants who were not diabetic, acutely unwell (post stroke, post surgery), pregnant, or using insulin pumps. EVIDENCE SYNTHESIS: A total of 1636 records were identified, and 1602 were excluded, leaving 34 publications in the final review. Of the 20 852 total participants, 663 had type 1 diabetes (T1D) and 19 909 had type 2 diabetes (T2D). Glycemic variability and low time in range (TIR) showed associations with all studied microvascular and macrovascular complications of diabetes. Notably, higher TIR was associated with reduced risk of albuminuria, retinopathy, cardiovascular disease mortality, all-cause mortality, and abnormal carotid intima-media thickness. Peripheral neuropathy was predominantly associated with standard deviation of blood glucose levels (SD) and mean amplitude of glycemic excursions (MAGE). CONCLUSION: The evidence supports the association between diabetes complications and CGM-derived measures of intraday glycemic variability. TIR emerged as the most consistent measure, supporting its emerging role in clinical practice. More longitudinal studies and trials are required to confirm these associations, particularly for T1D, for which there are limited data.
引用
- Yapanis M, James S, Craig ME, et al. Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring. J Clin Endocrinol Metab. 2022. PMID: 35094087. doi:10.1210/clinem/dgac034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。